Atrial fibrillation (AF) is an important risk factor for ischemic stroke resulting in a fivefold
increased stroke risk and a twofold increased mortality. Our understanding of stroke …

New‐onset atrial fibrillation (NAF) is increased in the type 2 diabetic patient because of the
presence of the metaboli syndrome and increased sympathetic activity. This results in …

Background: Atrial fibrillation is the most common sustained arrhythmia and is associated
with cardiovascular morbidity and mortality. The few studies conducted on short-term effects …

Ablation of non-pulmonary vein (PV) triggers is an important step to improve outcomes in
atrial fibrillation ablation. Non-pulmonary vein triggers typically originates from predictable …

The pathophysiology of atrial fibrillation (AF) is broad, with components related to the unique
and diverse cellular electrophysiology of atrial myocytes, structural complexity, and …

Background: Atrial fibrillation (AF), the most common cardiac arrhythmia, is characterized by
alteration of the action potential (AP) propagation. Under persistent AF, myocytes undergo …

The interventional therapy for cardiac arrhythmias is an irreplaceable part of modern
cardiological therapy. The development in the field of 3-D mapping systems and catheter …

Atrial fibrillation (AF) is the most common clinically relevant arrhythmia in horses, with a
reported prevalence up to 2.5%. The pathophysiology has mainly been investigated in …

Heart rhythm disorders, arrhythmias, place a huge economic burden on society and have a
large impact on the quality of life of a vast number of people. Arrhythmias can have genetic …

Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice with a large
socioeconomic impact due to its associated morbidity, mortality, reduction in quality of life …